|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.995 USD | +0.71% |
|
-2.46% | -68.62% |
| 12-03 | Orion Lifts FY25 Outlook on Expectation of Milestone Payment for Prostate Cancer Drug | MT |
| 11-19 | Orion S.A. Gains Commercial Traction with Conductive Additives Vital for Grid Modernization | CI |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 5 | |||||||
| 20 | |||||||
| 19 | |||||||
| 19 | |||||||
| 13 | |||||||
| 16 | |||||||
| 12 | |||||||
| 6 | |||||||
| 23 | |||||||
| 26 | |||||||
| 18 | |||||||
| 3 | |||||||
| - | - | - | - | - | 5 | ||
| 4 | |||||||
| 13 | |||||||
| 17 | |||||||
| 10 | |||||||
| 7 | |||||||
| 9 | |||||||
| Average | 13 | |||||||
| Weighted average by Cap. | 16 |
- Stock Market
- Equities
- OEC Stock
- Sector Orion S.A.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition